Wai Yuen Tong Medicine Holdings Limited (HKG:0897)

HKG:0897 Revenue

In the fiscal year ending March 31, 2026, Wai Yuen Tong Medicine Holdings had annual revenue of 683.44M HKD, down -8.30%. Wai Yuen Tong Medicine Holdings had revenue of 360.63M in the half year ending March 31, 2026.

• Revenue: 683.44M
• Revenue Growth: -8.30%
• P/S Ratio: 0.52
• Revenue / Employee: 989.06K
• Employees: 691
• Market Cap: 356.60M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	683.44M	-61.86M	-8.30%
Mar 31, 2025	745.30M	-38.58M	-4.92%
Mar 31, 2024	783.88M	60.28M	8.33%
Mar 31, 2023	723.60M	-667.81M	-48.00%
Mar 31, 2022	1.39B	282.85M	25.51%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 2, 2026

Data Sources Report a data error